Suppression of AKT Activation Through LZK Inhibition Limits Tumor Growth in Esophageal and Head and Neck Cancers.

Katerji M, Rubin MR, Lindberg E, Torres-Ayuso P, Siddiqui A, Funk AL, Nyswaner K, Woodroofe CC, Wolfe S, Edwards ZC, Trotter EW, Baloglu E, Ahel I, Marusiak AA, Newton A, Cachau RE, Arnold K, Swenson RE, Brognard J

Open source

DOI
10.1158/1535-7163.mct-25-1042
Published
2026 Jun 2
Container
Molecular cancer therapeutics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/1535-7163.mct-25-1042,
  title = {Suppression of AKT Activation Through LZK Inhibition Limits Tumor Growth in Esophageal and Head and Neck Cancers.},
  author = {Katerji M and Rubin MR and Lindberg E and Torres-Ayuso P and Siddiqui A and Funk AL and Nyswaner K and Woodroofe CC and Wolfe S and Edwards ZC and Trotter EW and Baloglu E and Ahel I and Marusiak AA and Newton A and Cachau RE and Arnold K and Swenson RE and Brognard J},
  year = {2026},
  journal = {Molecular cancer therapeutics},
  doi = {10.1158/1535-7163.mct-25-1042},
  url = {https://doi.org/10.1158/1535-7163.mct-25-1042}
}

RIS

TY  - JOUR
TI  - Suppression of AKT Activation Through LZK Inhibition Limits Tumor Growth in Esophageal and Head and Neck Cancers.
AU  - Katerji M
AU  - Rubin MR
AU  - Lindberg E
AU  - Torres-Ayuso P
AU  - Siddiqui A
AU  - Funk AL
AU  - Nyswaner K
AU  - Woodroofe CC
AU  - Wolfe S
AU  - Edwards ZC
AU  - Trotter EW
AU  - Baloglu E
AU  - Ahel I
AU  - Marusiak AA
AU  - Newton A
AU  - Cachau RE
AU  - Arnold K
AU  - Swenson RE
AU  - Brognard J
PY  - 2026
JO  - Molecular cancer therapeutics
DO  - 10.1158/1535-7163.mct-25-1042
UR  - https://doi.org/10.1158/1535-7163.mct-25-1042
ER  - 

APA

M, K., MR, R., E, L., P, T., A, S., AL, F., K, N., CC, W., S, W., ZC, E., EW, T., E, B., I, A., AA, M., A, N., RE, C., K, A., RE, S., & J, B. (2026). Suppression of AKT Activation Through LZK Inhibition Limits Tumor Growth in Esophageal and Head and Neck Cancers.. Molecular cancer therapeutics. https://doi.org/10.1158/1535-7163.mct-25-1042

Source records